TKNO vs. WVE, BLTE, GLPG, ARQT, INDV, AKRO, DYN, IMCR, EVO, and TVTX
Should you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Wave Life Sciences (WVE), Belite Bio (BLTE), Galapagos (GLPG), Arcutis Biotherapeutics (ARQT), Indivior (INDV), Akero Therapeutics (AKRO), Dyne Therapeutics (DYN), Immunocore (IMCR), Evotec (EVO), and Travere Therapeutics (TVTX). These companies are all part of the "pharmaceutical products" industry.
Alpha Teknova vs.
Alpha Teknova (NASDAQ:TKNO) and Wave Life Sciences (NASDAQ:WVE) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, community ranking, earnings, profitability, valuation, institutional ownership and risk.
Alpha Teknova has a beta of 0.34, meaning that its stock price is 66% less volatile than the S&P 500. Comparatively, Wave Life Sciences has a beta of -1.07, meaning that its stock price is 207% less volatile than the S&P 500.
13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 89.7% of Wave Life Sciences shares are held by institutional investors. 15.2% of Alpha Teknova shares are held by insiders. Comparatively, 29.1% of Wave Life Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Wave Life Sciences had 3 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for Wave Life Sciences and 0 mentions for Alpha Teknova. Wave Life Sciences' average media sentiment score of 0.54 beat Alpha Teknova's score of 0.00 indicating that Wave Life Sciences is being referred to more favorably in the news media.
Wave Life Sciences received 355 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 67.85% of users gave Wave Life Sciences an outperform vote while only 36.36% of users gave Alpha Teknova an outperform vote.
Wave Life Sciences has a net margin of -66.50% compared to Alpha Teknova's net margin of -87.17%. Alpha Teknova's return on equity of -35.30% beat Wave Life Sciences' return on equity.
Alpha Teknova presently has a consensus price target of $5.00, suggesting a potential downside of 38.04%. Wave Life Sciences has a consensus price target of $22.22, suggesting a potential upside of 102.20%. Given Wave Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Wave Life Sciences is more favorable than Alpha Teknova.
Alpha Teknova has higher earnings, but lower revenue than Wave Life Sciences. Alpha Teknova is trading at a lower price-to-earnings ratio than Wave Life Sciences, indicating that it is currently the more affordable of the two stocks.
Summary
Wave Life Sciences beats Alpha Teknova on 14 of the 19 factors compared between the two stocks.
Get Alpha Teknova News Delivered to You Automatically
Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alpha Teknova Competitors List
Related Companies and Tools
This page (NASDAQ:TKNO) was last updated on 1/21/2025 by MarketBeat.com Staff
Free TKNO Stock Alerts